Professional statement
Dr Paul Mulholland is a highly experienced consultant medical oncologist based in London. He exclusively treats brain cancer, specialising in brain tumours, metastasis, neuroendocrine tumours, immunotherapy and clinical trials.
He serves as a consultant at University College Hospital, the National Hospital for Neurology and Neurosurgery (part of UCLH), and Mount Vernon Cancer Centre. Additionally, he chairs the HCA Cancer Care brain and CNS tumour board.
Dr. Mulholland holds the position of honorary senior lecturer at University College London and serves as a training programme director. His doctoral research at the Cancer Research UK London Research Institute focused on genomic profiling in brain cancer, laying the foundation for his work on biomarkers and therapy targets in this field. He currently oversees a clinical trial portfolio of novel agents in brain cancer at UCLH and on a national scale.
Additionally, he holds the role of the clinical lead within Datrix, a European Consortium focused on advancing next-generation targeted hyperthermic cancer treatment for glioblastoma through multidisciplinary collaboration.
Clinics
Amethyst: The Queen Square Neuroscience Health Centre
Central London, 42-43 Queen Square London WC1N 3AQMedical insurances accepted
Credentials
Professional experience
- 33 years of experience
- Consultant Medical Oncologist, Queen Square Neuroscience Health Centre (present)
Subspecialties
- Glioblastoma
- Oligodendroglioma
Professional memberships
- Royal Colleges of Physicians of the United Kingdom
Education
- MBBS, University of London (1992)
- MSc, University of Birmingham (2000)
Teaching posts
- Honorary Senior Lecturer, University College London
- Training Programme Director, University College London
Positions in organisations
- Chair, HCA Cancer Care brain and CNS tumour board
- Clinical Lead, Datrix
Publications and conferences
- You can read some of Dr Mulholland's publications on ResearchGate.
Languages spoken
- English